Open AccessSexual Dysfunction in Male Subjects Receiving Trifluoperazine, Risperidone, or Olanzapine
Author(s) -
Naresh Nebhinani,
Sandeep Grover,
Ajit Avasthi
Publication year - 2012
Publication title -
primary care companion to cns disorders/the primary care companion for cns disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 50
eISSN - 2155-7772
pISSN - 2155-7780
DOI - 10.4088/pcc.11m01199
Subject(s) - sexual dysfunction , risperidone , olanzapine , sexual function , psychology , trifluoperazine , libido , psychiatry , medicine , schizophrenia (object oriented programming) , calmodulin , calcium
To assess the rate and typology of sexual dysfunction in male subjects receiving trifluoperazine, risperidone, or olanzapine using the Arizona Sexual Experience Scale (ASEX), the Psychotropic Related Sexual Dysfunction Questionnaire (PRSexDQ), and the sexual function section of the modified Udvalg for Kliniske Undersøgelser Side Effect Rating Scale (UKU).